These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27816428)

  • 1. Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1.
    Lorenz F; Pawłowicz E; Klimkowska M; Beshara S; Bulanda Brustad A; Skotnicki AB; Wahlin A; Machaczka M
    Blood Cells Mol Dis; 2018 Feb; 68():35-42. PubMed ID: 27816428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease.
    Medrano-Engay B; Irun P; Gervas-Arruga J; Andrade-Campos M; Andreu V; Alfonso P; Pocovi M; Giraldo P
    Blood Cells Mol Dis; 2014 Dec; 53(4):171-5. PubMed ID: 25153906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease.
    Lefebvre T; Reihani N; Daher R; de Villemeur TB; Belmatoug N; Rose C; Colin-Aronovicz Y; Puy H; Le Van Kim C; Franco M; Karim Z
    Haematologica; 2018 Apr; 103(4):587-596. PubMed ID: 29305416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.
    Gervas-Arruga J; Cebolla JJ; de Blas I; Roca M; Pocovi M; Giraldo P
    PLoS One; 2015; 10(5):e0126153. PubMed ID: 25978039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications.
    Regenboog M; van Kuilenburg AB; Verheij J; Swinkels DW; Hollak CE
    Blood Rev; 2016 Nov; 30(6):431-437. PubMed ID: 27265538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
    Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
    An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment.
    Mekinian A; Stirnemann J; Belmatoug N; Heraoui D; Fantin B; Fain O; Charpentier A; Rose C
    Blood Cells Mol Dis; 2012 Jun; 49(1):53-7. PubMed ID: 22560483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients.
    Machaczka M; Paucar M; Björkvall CK; Smith NJC; Cox TM; Forsgren L; Svenningsson P
    Blood Cells Mol Dis; 2018 Feb; 68():86-92. PubMed ID: 27789132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron metabolism in patients with anorexia nervosa: elevated serum hepcidin concentrations in the absence of inflammation.
    Papillard-Marechal S; Sznajder M; Hurtado-Nedelec M; Alibay Y; Martin-Schmitt C; Dehoux M; Westerman M; Beaumont C; Chevallier B; Puy H; Stheneur C
    Am J Clin Nutr; 2012 Mar; 95(3):548-54. PubMed ID: 22301927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of inflammatory parameters, Brain-derived neurotrophic factor levels and global histone H4 acetylation status in peripheral blood of patients with Gaucher disease type 1.
    de Mello AS; da Silva IR; Reinaldo GP; Dorneles GP; Cé J; Lago PD; Peres A; Elsner VR; Coelho JC
    Clin Biochem; 2017 Mar; 50(4-5):228-233. PubMed ID: 27865783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity.
    Andrews M; Soto N; Arredondo-Olguín M
    Nutrition; 2015 Jan; 31(1):51-7. PubMed ID: 25441587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose vitamin D
    Smith EM; Alvarez JA; Kearns MD; Hao L; Sloan JH; Konrad RJ; Ziegler TR; Zughaier SM; Tangpricha V
    Clin Nutr; 2017 Aug; 36(4):980-985. PubMed ID: 27402475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk.
    An P; Wang H; Wu Q; Guo X; Wu A; Zhang Z; Zhang D; Xu X; Mao Q; Shen X; Zhang L; Xiong Z; He L; Liu Y; Min J; Zhou D; Wang F
    Sci Rep; 2015 Aug; 5():13106. PubMed ID: 26290281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Khan A; Hangartner T; Weinreb NJ; Taylor JS; Mistry PK
    J Bone Miner Res; 2012 Aug; 27(8):1839-48. PubMed ID: 22692814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.
    Brudevold R; Hole T; Hammerstrøm J
    PLoS One; 2008; 3(10):e3547. PubMed ID: 18958176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment.
    Regenboog M; Bohte AE; Akkerman EM; Stoker J; Hollak CEM
    Br J Haematol; 2017 Nov; 179(4):635-647. PubMed ID: 28905365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.